Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease

NCT07428447 is registered in ClinicalTrials.gov with CND Life Sciences as lead sponsor.

NCT NCT07428447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07428447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease
Lead sponsor
CND Life Sciences
Phase
Observational
Overall status
Recruiting
Start date
February 18, 2026
Completion date
February 28, 2029
Enrollment
300 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

essential tremor, essential tremor, movement disorders, essential tremor-plus